Equillium, Inc.

US$1.51As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EQHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (24.24%)
Div yield —
ROE (58.98%)
Biotechnology
Beta (5Y) 2.04
PE TTM —
TSR TTM 7.09%
Mkt cap US$118.3M
ROIC (38.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.81
19.95%
(89.49%)
Hold 5|12|1|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
15.08%
16.23%
12.46%
22.44%
Revenue$M
9.343
9.267
9.236
9.087
(1.38%)
(6.52%)
(4.36%)
(4.90%)
Peers (US$118.3M)
Cap (US$)
PE
118.3M
—
117.9M
19.70x
Capital
TTM
5Y
10Y
Leveragex
1.776
0.148
0.145
EBIT/Intx
1.085
0.163
0.159
Own earn%
(8.08)
(108.82)
(103.29)
Sh yield%
33.24
26.98
26.39
Owners
Insiders/Inst%
7.36
53.95
Short interest%
4.46
SBC / revenue%
5.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
12–18
$1 testx
—
Incr. ROIC%
7